DIOSynVax Revenue and Competitors
Estimated Revenue & Valuation
- DIOSynVax's estimated annual revenue is currently $3.6M per year.
- DIOSynVax's estimated revenue per employee is $155,000
Employee Data
- DIOSynVax has 23 Employees.
- DIOSynVax grew their employee count by 53% last year.
DIOSynVax's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Senior Project Manager | Reveal Email/Phone |
4 | Scientist, Vaccinology & Analytical Project Manager | Reveal Email/Phone |
5 | Immunologist | Reveal Email/Phone |
6 | Team Lead, Vaccine Antigen Payload Development | Reveal Email/Phone |
7 | Senior Bioinformatician | Reveal Email/Phone |
8 | Postdoctoral Research Fellow | Reveal Email/Phone |
9 | Team Leader in Vaccine Development | Reveal Email/Phone |
10 | Bioinformatics Analyst | Reveal Email/Phone |
DIOSynVax Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is DIOSynVax?
DIOSVax is a biotech startup working to revolutionise the way humanity protects itself from infectious disease and emerging pathogens. The company is named after its core technology, DIOSynVax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines), a new system that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
keywords:N/A
N/A
Total Funding
23
Number of Employees
$3.6M
Revenue (est)
53%
Employee Growth %
N/A
Valuation
N/A
Accelerator
DIOSynVax News
DIOSynVax, a UK start-up founded by a vet-turned-vaccinologist, is hoping genetic sequences of viruses discovered in animal faeces will give...
It has awarded small grants to manufacturers including the UK's DIOSynVax and MigVax of Israel. Among the major Western COVID vaccine makers...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.7M | 23 | -4% | $8M |
#2 | $1.8M | 23 | -34% | $108.9M |
#3 | $2.9M | 23 | 0% | N/A |
#4 | $2.3M | 23 | -38% | N/A |
#5 | $2.3M | 23 | -23% | N/A |